ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

Delayed Data
As of 3:59pm ET
 +0.35 / +1.50%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 33.00, with a high estimate of 42.00 and a low estimate of 13.00. The median estimate represents a +39.59% increase from the last price of 23.64.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1,802.53%
Growthannually 76.75%


Growthquarterly 14.98%
Growthannually 31.34%
Key to the earnings and sales forecast charts.